Generation of one induced pluripotent stem cell line JUCGRMi004-A from a Charcot-Marie-Tooth disease type 1A (CMT1A) patient with PMP22 duplication by Xing Liu, Kei-ichi Ishikawa, Nobutaka Hattori, Wado Akamatsu

Get full text

A defined method for differentiating human iPSCs into midbrain dopaminergic progenitors that safely restore motor deficits in Parkinson’s disease by Ryota Nakamura, Risa Nonaka, Risa Nonaka, Risa Nonaka, Genko Oyama, Takayuki Jo, Hikaru Kamo, Maierdanjiang Nuermaimaiti, Maierdanjiang Nuermaimaiti, Wado Akamatsu, Kei-ichi Ishikawa, Kei-ichi Ishikawa, Kei-ichi Ishikawa, Nobutaka Hattori, Nobutaka Hattori, Nobutaka Hattori, Nobutaka Hattori, Nobutaka Hattori, Nobutaka Hattori

Get full text

Generation of a control iPS cell line (JUCGRMi005-A) with no abnormalities in Parkinson's disease-related genes by Kei-ichi Ishikawa, Takahiro Shiga, Manabu Funayama, Nobutaka Hattori, Wado Akamatsu

Get full text

Generation of a control iPS cell line (JUCGRMi006-A) with no abnormalities in Parkinson's disease-related genes by Kei-ichi Ishikawa, Takahiro Shiga, Manabu Funayama, Nobutaka Hattori, Wado Akamatsu

Get full text

Generation of hiPSCs (JUCGRMi003-A) from a patient with Parkinson’s disease with PARK2 mutation by Kei-ichi Ishikawa, Ayami Okuzumi, Hiroyo Yoshino, Nobutaka Hattori, Wado Akamatsu

Get full text

Reduced ER-mitochondrial contact sites and mitochondrial Ca2+ flux in PRKN-mutant patient tyrosine hydroxylase reporter iPSC lines by Mutsumi Yokota, Yutaro Yoshino, Mitsuko Hosoi, Ryota Hashimoto, Soichiro Kakuta, Takahiro Shiga, Kei-Ichi Ishikawa, Kei-Ichi Ishikawa, Hideyuki Okano, Nobutaka Hattori, Nobutaka Hattori, Wado Akamatsu, Masato Koike

Get full text

Generation of three hiPSC clones from a Parkinson’s disease patient with a heterozygous variant of VPS35 p.D620N by Kei-ichi Ishikawa, Mayu Ishiguro, Yuanzhe Li, Kenya Nishioka, Nobutaka Hattori, Wado Akamatsu

Get full text

Generation of three clones (JUCGRMi002-A, B, C) of induced pluripotent stem cells from a Parkinson’s disease patient with SNCA duplication by Kei-ichi Ishikawa, Takahiro Shiga, Hiroyo Yoshino, Kenya Nishioka, Nobutaka Hattori, Wado Akamatsu

Get full text

A Cell-Based High-Throughput Screening Identified Two Compounds that Enhance PINK1-Parkin Signaling by Kahori Shiba-Fukushima, Tsuyoshi Inoshita, Osamu Sano, Hidehisa Iwata, Kei-ichi Ishikawa, Hideyuki Okano, Wado Akamatsu, Yuzuru Imai, Nobutaka Hattori

Get full text

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy. by Akio Mori, Kei-Ichi Ishikawa, Shinji Saiki, Taku Hatano, Yutaka Oji, Ayami Okuzumi, Motoki Fujimaki, Takahiro Koinuma, Shin-Ichi Ueno, Yoko Imamichi, Nobutaka Hattori

Get full text

Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease by Shin-Ichi Ueno, Shinji Saiki, Motoki Fujimaki, Haruka Takeshige-Amano, Taku Hatano, Genko Oyama, Kei-Ichi Ishikawa, Akihiro Yamaguchi, Shuko Nojiri, Wado Akamatsu, Nobutaka Hattori

Get full text

Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2 by Satoru Torii, Satoko Arakawa, Shigeto Sato, Kei‐ichi Ishikawa, Daisuke Taniguchi, Hajime Tajima Sakurai, Shinya Honda, Yuuichi Hiraoka, Masaya Ono, Wado Akamatsu, Nobutaka Hattori, Shigeomi Shimizu

Get full text